Point of care monitors for oral anticoagulant therapy

Seminars in Thrombosis and Hemostasis

Volumn 30, Issue 6, 2004, Pages 697-702

  Nutescu, Edith A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

International Normalized Ratio; Monitoring; Oral anticoagulants; Point of care devices; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ACCURACY; AMBULATORY MONITORING; BLOOD CLOTTING; CALIBRATION; CONFERENCE PAPER; DEVICE; DIAGNOSTIC KIT; DRUG MONITORING; HOME MONITORING; HOSPITAL INFORMATION SYSTEM; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; MEDICAL TECHNOLOGY; PERFORMANCE; PRIORITY JOURNAL; PROTHROMBIN TIME;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; MONITORING, AMBULATORY; POINT-OF-CARE SYSTEMS; PROTHROMBIN TIME;

EID: 11144348998     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-861512     Document Type: Conference Paper

References (43)

1. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest 2001;119:22S-38S
2. Quick AJ. The prothrombin in hemophilia and in obstructive jaundice. J Biol Chem 1935;109:73-74
3. Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991;324:1865-1875
4. WHO Expert Committee on Biological Standardization: twenty-eighth report. World Health Organ Tech Rep Ser 1977;610:14-16, 45-51
5. Hirsh J, Poller L. The international normalized ratio. Arch Intern Med 1994;154:282-288
6. Koerner SD, Fuller RE. Comparison of a portable capillary whole blood coagulation monitor and standard laboratory methods for determining International Normalized Ratio. Mil Med 1998;163:820-825
7. Tripodi A, Chantarangkul V, Mannucci PM. Near-patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 2001;113:847-852
8. van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 2001;12:35-40
9. Anderson DR, Harrison L, Hirsch J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulation therapy. Arch Intern Med 1993;153:1441-1447
10. Foulis PR, Wallach PM, Adelman HM, et al. Performance of the Coumatrak system in a large anticoagulation clinic. Am J Clin Pathol 1995;103:98-102
11. Lucas FV, Duncan A, Jay R, et al. A novel whole blood capillary technique for measuring the prothrombin time. Am J Clin Pathol 1987;8:442-446
12. Yano Y, Kambayashi J, Murata K, et al. Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. Thromb Res 1992;66:583-590
13. Weibert RT, Adler DS. Evaluation of a capillary whole blood prothrombin time measurement system. Clin Pharm 1989;8:864-867
14. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992;152:589-592
15. Tripodi A, Arbini AA, Chantarangkul V, et al. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio? Thromb Haemost 1993;70:921-924
16. Roche Diagnostics Corp. Package insert: CoaguChek™ S. Indianapolis. IN: Roche Diagnostics; 2002
17. Bayer Diagnostics. Package insert: Rapidpoint Coag™. Tarrytown, NY: Bayer Diagnostics/Pharmanetics Inc.; 2002
18. Rose VL, Dermott SC, Murray BF, et al. Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzer. Arch Pathol Lab Med 1993;117:611-617
19. Oberhardt BJ, Dermott SC, Taylor M, et al. Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clin Chem 1991;37:520-526
20. Kapiotis S, Quehenberger P, Speiser W. Evaluation of the new method Coaguchek for the determination of prothrombin time from capillary blood: comparison with Thrombotest on KC-1. Thromb Res 1995;77:563-567
21. van den Besselaar AM. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000;84:410-412
22. van den Besselaar AM, Meeuwisse-Braun J, Schaefer-van Mansfeld H, van Rijn C, Witteveen E. A comparison between capillary and venous blood international normalized ratio determinations in a portable prothrombin time device. Blood Coagul Fibrinolysis 2000;11:559-562
23. Kaatz SS, White RH, Hill J, et al. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med 1995;155:1861-1867
24. Biotrack, Inc. Package insert: ProTime® Microcoagulation System. Mountain View, CA: International Technidyne Corp; 2002
25. Oral Anticoagulation Monitoring Study Group. Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Oral Anticoagulation Monitoring Study Group. Am J Clin Pathol 2001;115:288-296
26. Pierce MT, Crain L, Smith J, Mehta V. Point-of-care versus laboratory measurement of the International Normalized Ratio. Am J Health Syst Pharm 2000;57:2271-2274
27. Chapman DC, Stephens MA, Hamann GL, et al. Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting. Ann Pharmacother 1999;33:775-780
28. Reed C, Rickman H. Accuracy of International Normalized Ratio determined by portable whole-blood coagulation monitor versus a central laboratory. Am J Health Syst Pharm 1999;56:1619-1623
29. Avocet, Inc. Package insert: AvoSure™ PT. San Jose, CA: Avocet Medical Inc.; 2000
30. De Miguel D, Burgaleta C, Reyes E, Pascual T. Capillary whole blood testing by a new portable monitor. Comparison with standard determination of the international normalized ratio. Am J Clin Pathol 2003;120:28-33
31. Rigelsky JM, Choe HM, Curtis DM, et al. Accuracy of the AvoSure PT Pro System compared with a hospital laboratory standard. Ann Pharmacother 2002;36:380-385
32. LifeScan, Inc. Package insert: Harmony™ INR Monitoring System. Milpitas, CA: LifeScan Inc./Johnson & Johnson; 2003
33. Earp B, Chow H, Sharma A. LifeScan INR monitor: system description and calibration traceability. J Thromb Thrombolysis 2001;12:110
34. Earp B, Hambleton J, Spencer F, Jacobson A. Accuracy and precision of the LifeScan INR monitor in anticoagulation clinics. J Thromb Thrombolysis 2001;12:109
35. HemoSense, Inc. Product information: INRatio™. Milpitas, CA: Hemosense, Inc.; 2003
36. Jacobson A, Peterson M, Gunnemann T, et al. Magnitude of INR variation attributable to differences between point-of-care testing devices. Thromb Haemost 2001;86(Suppl):802a.
37. Gosselin RC, Owings JT, White RH, et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost 2000;83:698-703
38. Ansell JE. Empowering patients to monitor and manage oral anticoagulation therapy. JAMA 1999;281:182-183
39. White RH, McCurdy SA, von Marensdorff H, et al. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med 1989;111:730-737
40. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. JAMA 1999;281:145-150
41. Ansell J, Patel N, Ostrovsky D, et al. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-2189
42. Bernardo A. Experience with patient self-management of oral anticoagulation. J Thromb Thrombolysis 1996;2:321-325
43. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomized cross-over comparison. Lancet 2000;356:97-102